logo

For the Inventor, By the Inventor

Cologne, Germany

Lonza Cologne Gmbh


USPTO Granted Patents = 26

% Expired Patents = 11.5



Trademarks = 5

Forward Citations = 98

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Timo Gleissner (16 out of 16 patents)

silverMedal Andreas Heinze (10 out of 10 patents)

bronzeMedal Herbert Mueller-Hartmann (10 out of 12 patents)

4.  Ludger Altrogge (9 out of 11 patents)

5.  Andreas Wirth (7 out of 7 patents)

6.  Gregor Siebenkotten (6 out of 10 patents)

7.  Sven Hermsmeier (5 out of 5 patents)

8.  Gudula Riemen (5 out of 8 patents)

9.  Juliana Helfrich (5 out of 7 patents)

10.  Elke Lorbach (5 out of 7 patents)

11.  Erika McAfee (4 out of 6 patents)

12.  Samatha Bandapalle (4 out of 6 patents)

13.  Ann Siehoff (4 out of 4 patents)

14.  Joseph O'Connor (4 out of 6 patents)

15.  Kelly Purpura (4 out of 5 patents)


Core Competencies:
Cell Suspension
Filling Level Control
Adherent Cell Treatment
Cell Therapy Automation
Large Volume Transfection
Electroporation
Electrical Treatment
Biologically Active Molecules
Modular Transfection Systems
Buffer Solutions
Electrode Assembly
Reaction Spaces

26 patents:

1. 12649896 - Device for providing a cell suspension (2026-06-09),
2. 12577521 - Method and device for controlling the filling level in a chamber (2026-03-17),
3. 12415998 - Method and device for uniformly treating adherent cells (2025-09-16),
4. 11827902 - End-to-end cell therapy automation (2023-11-28),
5. 11781113 - End-to-end cell therapy automation (2023-10-10),
6. 11661595 - Device and method for large volume transfection (2023-05-30),
7. 11447745 - End-to-end cell therapy automation (2022-09-20),
8. 11371018 - End-to-end cell therapy automation (2022-06-28),
9. 11352615 - Device and method for large volume transfection (2022-06-07),
10. 11021698 - Method and device for uniformly treating adherent cells (2021-06-01),
11. 10633646 - Device and method for large volume transfection (2020-04-28),
12. 10336996 - Device and method for large volume transfection (2019-07-02),
13. 9701954 - Method and device for uniformly treating adherent cells (2017-07-11),
14. 9624486 - Method and electrode assembly for treating adherent cells (2017-04-18),
15. 9284525 - Method and a device for the electrical treatment of a plurality of containers (2016-03-15),
Company Overview
Lonza Cologne GmbH is a prominent player in the life sciences sector, specializing in the development and manufacturing of biopharmaceuticals and advanced materials. The company focuses on providing innovative solutions for the pharmaceutical and biotechnology industries, leveraging cutting-edge technologies to enhance drug development and production processes. With a strong commitment to quality and sustainability, Lonza Cologne operates within a global framework, contributing significantly to advancements in healthcare and related fields.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Lonza Cologne Gmbh USPTO Patent Assignee Logo
26 Patents

#28 in Cologne

#1,786 in Germany

#24,806 in the World

Cologne, DE
Cologne, Germany

Lonza Cologne Gmbh

Forward Citations = 98

43 inventors:

goldMedal Timo Gleissner (16 out of 16 patents)

silverMedal Andreas Heinze (10 out of 10 patents)

bronzeMedal Herbert Mueller-Hartmann (10 out of 12 patents)

4.  Ludger Altrogge (9 out of 11 patents)

5.  Andreas Wirth (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lonza Cologne Gmbh. Retrieved from https://idiyas.com/company/lonza-cologne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…